|
Variable
|
Frequency
|
Median survival
|
Log Rank
|
|---|
|
Gender
| | |
N.S.
|
|
Female
|
146
|
2.9 M
| |
|
Male
|
193
|
2.1 M
| |
|
Age
| | |
p = 0.0002
|
|
30–49
|
37
|
7.0 M
| |
|
50–69
|
184
|
2.5 M
| |
|
70–90
|
118
|
1.5 M
| |
|
KPS
| | |
p = 0.0001
|
|
90–100%
|
94
|
5.2 M
| |
|
70–80%
|
138
|
2.5 M
| |
|
< 70%
|
107
|
1.2 M
| |
|
Time of occurrence
| | |
N.S.
|
|
Synchronous with primary
|
130
|
2.8 M
| |
|
After primary
|
209
|
2.4 M
| |
|
Hospitalization
| | |
p = 0.0001
|
|
Yes
|
126
|
0.9 M
| |
|
No
|
213
|
3.5 M
| |
|
Number of brain metastases
| | |
p = 0.031
|
|
Singular/solitary
|
65
|
3.7 M
| |
|
≤ 3
|
75
|
2.6 M
| |
|
> 3 or bulk
|
199
|
2.3 M
| |
|
Primary disease status
| | |
p = 0.0244
|
|
Controlled primary
|
64
|
3.8 M
| |
|
Uncontrolled primary
|
275
|
2.3 M
| |
|
Tumor site (3 most common and other)
| | |
N.S.
|
|
NSCLC
|
148
|
2.5 M
| |
|
SCLC
|
59
|
2.4 M
| |
|
Breast cancer
|
47
|
2.9 M
| |
|
Other
|
85
| | |
- Demographic data of the 339 patients with univariate analysis of potential risk factors for median survival. N.S. no significant difference
